The 10 Most Innovative Bioeconomy CEOs 2022. Now choose the number 1

wpid-20150618_135539.jpg
“Bioeconomy in everyday life” @ BioBased World 2015 in Frankfurt am Main

The circular bioeconomy is innovation, the result of the skills and passion of researchers and managers able to create value and new high-qualified jobs, reconciling economy, society and the environment. At the end of 2014 Il Bioeconomista launched a new initiative: The 10 Most Innovative Bioeconomy CEOs.

We have asked a panel of world bioeconomy experts to tell us the Chief Executive Officers that have stood out as the most innovative during the last year.

Now we ask you to choose the most innovative CEO responding to our survey (open till December 13 at 7 am, Western European Time).

The most innovative CEO 2016 was Ken Richards (CEO of Leaf Resources, Australia)

The most innovative CEO 2017 was Tony Duncan (CEO of Circa Group, Australia)

The most innovative CEO 2018 was Jürgen Eck (CEO of BRAIN AG, Germany)

The most innovative CEO 2019 was Alex Michine (CEO of MetGen, Finland)

The most innovative CEO 2020 was Simão Soares (CEO of SilicoLife, Portugal)

The most innovative CEO 2021 was Jennifer Holmgren (CEO of LanzaTech, USA)

This is the result of 2022 (in alphabetical order)

Catia Bastioli, Novamont (Italy)

Dominique Boies, Enerkem (Canada)

Mathieu Flamini, GFBiochemicals (France)

Jennifer Holmgren, LanzaTech (USA)

Philippe Lacamp, SkyNRG (The Netherlands)

Matt Lipscomb, DMC Biotechnologies (USA)

Eric A. McAfee, Aemetis (USA)

Christophe Schilling, Genomatica (USA)

Nicolas Sordet, Afyren (France)

Tom van Aken, Avantium (The Netherlands)

An exclusive interview with Christophe Schilling, CEO of Genomatica

Christophe Schilling, CEO of Genomatica

Christophe Schilling founded Genomatica in 1998. Since being named CEO in May 2009, he has led Genomatica to widespread recognition as a leader in industrial biotech, with a commercialized first process and plant and multiple leading partners. The company has earned awards for industry impact (recognized in ICIS Top40 Power Players five years in a row), engineering (Kirkpatrick), science (EPA Presidential Green Chemistry), industry leadership (voted #1 Hottest four years in a row by Biofuels Digest), and company culture (The Scientist as a Best Place to Work). Christophe is Chairman of Biocom, the largest advocate organization for California’s life sciences sector; serves on BIO’s Industrial & Environmental Section Governing Board; serves on the World Economic Forum Global Agenda Council on Biotechnology; and is a member of YPO, an international leadership organization for chief executives. In this exclusive interview with Il Bioeconomista, he talks about the recent agreement with Covestro and the Genomatica’s way towards the bioeconomy.

Interview by Mario Bonaccorso

Continue reading

Christophe Schilling talks to Il Bioeconomista. An exclusive interview with the CEO of Genomatica

Christophe Schilling, CEO of Genomatica during his speech at the Grand Opening of Mater Biotech's plant in Bottrighe di Adria, Italy
Christophe Schilling, CEO of Genomatica, at the Grand Opening of Mater Biotech’s plant in Bottrighe di Adria, Italy

“Biotech is becoming increasingly important to the mainstream chemical industry as the demand for more sustainable solutions intensifies. Biotech is especially well-suited to help with some of the industry’s biggest challenges”. To say it – in this exclusive interview with Il Bioeconomista – is Christophe Schilling, founder and CEO of Genomatica, a widely-recognized bioengineering leader for the chemical industry. The San Diego-based biotechnology company develops and licenses bio-based manufacturing processes for the production of intermediate and basic chemicals.

Since being named CEO in May 2009, Christophe Schilling has led Genomatica to widespread recognition as a leader in industrial biotechnology, with a commercialized first process, top-tier licensees, strong investors and an unrivaled string of awards for engineering (Kirkpatrick), science (EPA Presidential Green Chemistry), industry leadership (voted #1 Hottest three years in a row by Biofuels Digest), and company culture (The Scientist as a Best Place to Work). Schilling frequently speaks on industry trends at major conferences and serves as a member of the World Economic Forum Global Agenda Council on Biotechnology.

Interview by Mario Bonaccorso

Continue reading